Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (4) , 2918-2923
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81671417, 81370688)
- Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ010616)
- Shanghai Science and Technology Development (17411961000)
- Municipal Human Resources Development Program
- Medical Disciplines in Shanghai (2017BR035)
This publication has 35 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- High-temperature requirement factor A3 (Htra3): A novel serine protease and its potential role in ovarian function and ovarian cancersMolecular and Cellular Endocrinology, 2010
- Influence of ovarian stage on transcript profiles in fathead minnow (Pimephales promelas) ovary tissueAquatic Toxicology, 2010
- High Temperature Requirement A3 (HtrA3) Promotes Etoposide- and Cisplatin-induced Cytotoxicity in Lung Cancer Cell LinesJournal of Biological Chemistry, 2010
- Hypoxia‐Inducible Factor‐1 as a Therapeutic Target in Endometrial Cancer ManagementObstetrics and Gynecology International, 2010
- Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in MiceCancer Research, 2008
- HTRA3 expression in non-pregnant rhesus monkey ovary and endometrium, and at the maternal-fetal interface during early pregnancyReproductive Biology and Endocrinology, 2008
- Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancerGynecologic Oncology, 2006
- Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profilingGenes, Chromosomes and Cancer, 2004
- Regulation of glucose transport by hypoxiaAmerican Journal of Kidney Diseases, 1999